<p><span style="color:#231F20;"><strong><u>BLADDER CANCER</u></strong></span></p><p style="margin-left:0cm;text-align:justify;"><span style="color:#231F20;">Bladder cancer is the second commonest urological cancer after prostate cancer.&nbsp;It is the commonest of all the cancers, which affect the urinary tract lining (urothelium). Males are more affected than females in a ratio of about 3:1. It is more common in the white race compared&nbsp; to the black race in a ratio of 4:1. More than 80% of clients with bladder cancer&nbsp;are&nbsp;above&nbsp;50&nbsp;years.&nbsp;The&nbsp;commonest&nbsp;pathological&nbsp;types&nbsp;are</span></p><p style="margin-left:0cm;"><span style="color:#231F20;">transitional cell carcinoma TCC (90%), Squamous cell carcinoma (8%) and adenocarcinoma and carcinoma in-situ (2%).</span></p><h3 style="margin-left:0cm;">CAUSES</h3><ul><li style="text-align:justify;">Chronic Infections of the bladder like <i>Schistosoma haematobium</i></li><li style="text-align:justify;">(Bilharzia) and chronic bacterial infections</li><li style="text-align:justify;">Smoking of cigarettes: cancer usually develops 10-20 years after smoking and 20 sticks a day/a packet carries a high risk of cancer development. Passive smoking may also carry the risk of cancer</li><li style="text-align:justify;">Occupational risks; environmental exposure to cancer-causing chemicals&nbsp;used&nbsp;in&nbsp;industries&nbsp;e.g.&nbsp;dye,&nbsp;textile, rubber,&nbsp;cable, printing etc.</li><li style="text-align:justify;">Genetic and familial factors</li></ul><h3 style="margin-left:0cm;">SYMPTOMS</h3><ul><li>May be asymptomatic in early disease&nbsp;(25%)</li><li>Haematuria&nbsp;(usually painless).&nbsp;Painful&nbsp;only&nbsp;in&nbsp;advanced disease&nbsp;and infection/UTI</li><li>Irritative symptoms: frequency, urgency,&nbsp;dysuria</li><li>Flank pain&nbsp;(hydronephrosis)</li><li>Pelvic pain from cancer&nbsp;invasion</li><li>Oedema&nbsp;of&nbsp;lower&nbsp;limbs from&nbsp;advanced&nbsp;disease</li></ul><h3 style="margin-left:0cm;">SIGNS</h3><ul><li>Pallor</li><li>Wasting</li><li>Palpable bladder&nbsp;mass</li></ul><p>&nbsp;</p><ul><li>Palpable&nbsp;kidney&nbsp;from&nbsp;ureteric obstruction&nbsp;and&nbsp;hydronephrosis</li><li>Lymphoedema of lower&nbsp;limb/limbs</li><li>Secondary UTI in 30% of&nbsp;cases</li></ul><h3 style="margin-left:0cm;">INVESTIGATIONS</h3><ul><li>FBC and&nbsp;ESR</li><li>Urine analysis and&nbsp;culture</li><li>Urine&nbsp;cytology</li><li>Urea, creatinine,&nbsp;electrolytes</li><li>Ultrasound scan:&nbsp;Abdominopelvic</li><li>CT Scan /MRI for staging (By&nbsp;specialist)</li><li>Special Investigations: Abdominopelvic&nbsp;IVU</li><li>Urethrocystoscopy and biopsies (By&nbsp;specialist)</li><li>Examination under anaesthesia (Bimanual palpation of bladder through DRE and Pelvic&nbsp;examinations).</li></ul><h3 style="margin-left:0cm;">TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>Surgical cure for early&nbsp;disease</li><li>Prevention&nbsp;of&nbsp;recurrence,&nbsp;progression&nbsp;and&nbsp;metastases</li><li>Management of&nbsp;complications</li><li>Additional treatment with cancer drugs and radiotherapy where necessary (Neoadjuvant and adjuvant&nbsp;therapy)</li></ul><h3 style="margin-left:0cm;">Non-pharmacological treatment</h3><ul><li>Cystectomy:&nbsp;Partial or&nbsp;radical&nbsp;with&nbsp;or&nbsp;without bladder&nbsp;replacement.</li><li>Radiotherapy</li></ul><h3 style="margin-left:0cm;">Pharmacological treatment</h3><p style="margin-left:0cm;"><span style="color:#231F20;">Evidence Rating: [C]</span></p><ol><li><span style="color:#231F20;">Early&nbsp;Stage</span></li></ol><p>BCG or Thiotepa bladder instillation for superficial tumours after&nbsp;</p><ul><li>Trans-Urethral&nbsp;Resection of&nbsp;Bladder&nbsp;Tumour&nbsp;(TURBT)</li></ul><ol><li><span style="color:#231F20;">Advanced&nbsp;Disease</span></li></ol><ul><li>Chemotherapeutic agents recommended for advanced stage include&nbsp;Methotrexate, Vinblastine, Adriamycin and&nbsp;Cisplatin.</li></ul><h3 style="margin-left:0cm;">&nbsp;</h3><p style="margin-left:0cm;">&nbsp;</p><h3 style="margin-left:0cm;">REFERRAL CRITERIA</h3><p style="margin-left:0cm;text-align:justify;"><span style="color:#231F20;">Refer all cases of bladder cancer for specialist evaluation and treatment. All cases of chronic cystitis should be referred to specialist to exclude bladder cancer.</span></p>